BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
Early pregnancy factor
,
Tamoxifen
,
rs3825942
,
DNMT1
,
Breast Cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
refractory relapsed multiple myeloma
Summary
General Info
Curated Studies
Most Correlated Studies
Multiple myeloma U266 cells with CD9 overexpression
Explore Curated Studies Results
Literature
Most Relevant Literature
CAR-T Therapy in Relapsed Refractory Multiple Myeloma.
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory…
Selinexor for the treatment of patients with relapsed or refractory multiple myeloma.
Optimization of treatment strategy for relapsed or refractory multiple myeloma].
Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023-A P…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
ABC294640 in Refractory / Relapsed Multiple Myeloma
Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma
Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma
Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple My…
A Study of BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ